2016-12-05 14:00:01 CET

2016-12-05 14:00:01 CET


English Finnish
Biohit Oyj - Financial Calendar

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2017


Biohit Oyj Stock Exchange Release, December 5, 2016 at 3:00 pm local time (EET)


  -- Biohit Oyj will release its financial statements for 2016 on Monday 20
th
 of February 2017 at 9:30 am.
  -- The Annual Report, which contains the Financial Statements for 2016 and the
     Report of the Board of Directors, will be published approximately during
     week 12.
  -- Biohit Oyj’s Annual General Meeting has been planned for Wednesday 26th of
     April 2017 at 5:00 pm. The Board of Directors will call the General Meeting
     at a later date.
  -- Half year financial report for period January-June (H1) 2017 on Thursday
     17th
 of August 2017 at 9:30 am.

The published economic reports and other stock exchange releases are available
on Biohit's website at www.biohithealthcare.com/investors. The website also
contains an online form for ordering electronic copies, which will be e-mailed
to you, available at
http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases
-to-your-email. 



Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com